Cargando…
Development of alternative splicing signature in lung squamous cell carcinoma
Increasing evidence demonstrated that alternative splicing (AS) plays a vital role in tumorigenesis and clinical outcome of patient. However, systematical analysis of AS in lung squamous cell carcinoma (LUSC) is lacking and greatly necessary. Thus, this study was to systematically estimate the funct...
Autores principales: | Yan, Jia-qing, Liu, Min, Ma, Ying-lin, Le, Kai-di, Dong, Bin, Li, Guo-hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004499/ https://www.ncbi.nlm.nih.gov/pubmed/33772655 http://dx.doi.org/10.1007/s12032-021-01490-1 |
Ejemplares similares
-
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020) -
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020) -
Emerging roles of alternative RNA splicing in oral squamous cell carcinoma
por: Liu, Miaomiao, et al.
Publicado: (2022) -
Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019) -
Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)